2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol
CAS:956905-27-4
Formula:
C19H16N8O
Purity:
%
Color and Shape:
Solid
Molecular weight:
372.3833
Ref: IN-DA01CP5X
5mg | 69.00 € | ||
10mg | 114.00 € | ||
50mg | 231.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
PF-04217903
CAS:956905-27-4
MET Tyrosine Kinase Inhibitor PF-04217903 is an orally bioavailabe, small-molecule tyrosine kinase inhibitor with potential …
Formula:
C19H16N8O
Purity:
98.41% - 98.55%
Color and Shape:
Solid
Molecular weight:
372.38
Ref: TM-T2676
1mg | 38.00 € | ||
2mg | 49.00 € | ||
5mg | 73.00 € | ||
10mg | 95.00 € | ||
25mg | 169.00 € | ||
50mg | 282.00 € | ||
100mg | 512.00 € | ||
1mL*10mM (DMSO) | 79.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
Ref: 7W-GW7535
1mg | 181.00 € | ||
5mg | 306.00 € | ||
10mg | 431.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
2-(4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-1H-pyrazol-1-yl)ethanol
CAS:956905-27-4
2-(4-(3-(Quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-1H-pyrazol-1-yl)ethanol is a compound that has been shown to have both prognostic and therapeutic potential …
Purity:
Min. 95%
Ref: 3D-FQ43314
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |